📊 CDRE Key Takeaways
Is Cadre Holdings, Inc. (CDRE) a Good Investment?
While Cadre Holdings demonstrates modest revenue growth (7.5%) and positive free cash flow generation, fundamental profitability metrics reveal severe operational challenges. The company's return on equity (0.6%) and return on assets (0.2%) are alarmingly low, indicating capital is being deployed with minimal efficiency. Most concerning, net income remained completely flat year-over-year despite revenue growth, signaling margin compression that raises questions about unit economics and operational leverage.
Cadre Holdings shows solid fundamental quality, with healthy revenue growth, strong gross margins, and disciplined cash conversion supported by low capital intensity. The balance sheet is liquid and debt appears manageable given very high interest coverage, though flat net income suggests margin expansion and earnings growth should be monitored more closely.
Cadre Holdings, Inc. Key Strengths (CDRE)
- Positive free cash flow generation of $19.8M with 12.8% FCF margin indicating cash generation capability
- Adequate liquidity position with current ratio of 2.26x and quick ratio of 1.33x
- Stable gross margin of 38.7% appropriate for orthopedic/surgical supplies sector
- Consistent positive operating cash flow of $22.5M supports operational viability
- Strong liquidity profile with a 3.50x current ratio and 2.54x quick ratio
- Healthy profitability, including 42.5% gross margin and double-digit operating margin
- Consistent cash generation with $56.85M of free cash flow and a 9.3% FCF margin
CDRE Stock Risks: Cadre Holdings, Inc. Investment Risks
- Critically low return on equity (0.6%) and return on assets (0.2%) indicate severe capital inefficiency
- Net income flat year-over-year despite 7.5% revenue growth indicates margin deterioration and cost pressures offsetting top-line gains
- Operating margin of 4.8% is dangerously thin and leaves minimal buffer for operational disruptions
- Elevated leverage at 1.04x debt-to-equity combined with weak profitability creates financial vulnerability
- Net profit margin of 1.3% provides insufficient earnings cushion relative to debt servicing requirements
- Net income was flat year over year despite 7.5% revenue growth, indicating limited operating leverage
- Debt remains meaningful at 0.92x debt-to-equity with $290.99M in long-term debt
- Moderate net margin of 7.2% leaves some sensitivity to cost inflation or mix shifts
Key Metrics to Watch
- Operating margin expansion trajectory - must demonstrate improvement from 4.8% to justify capital structure
- Return on equity recovery - current 0.6% is unacceptable and must improve materially
- Net income growth decoupling from flat trend - validate whether margin compression is temporary
- Debt reduction progress - debt-to-equity ratio must improve given profitability constraints
- Net income and operating margin progression relative to revenue growth
- Free cash flow conversion and debt reduction trends
Cadre Holdings, Inc. (CDRE) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.26x current ratio provides a solid financial cushion.
CDRE Profit Margin, ROE & Profitability Analysis
CDRE vs Healthcare Sector: How Cadre Holdings, Inc. Compares
How Cadre Holdings, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Cadre Holdings, Inc. Stock Overvalued? CDRE Valuation Analysis 2026
Based on fundamental analysis, Cadre Holdings, Inc. shows some fundamental concerns relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Cadre Holdings, Inc. Balance Sheet: CDRE Debt, Cash & Liquidity
CDRE Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Cadre Holdings, Inc.'s revenue has grown significantly by 43% over the 5-year period, indicating strong business expansion. The most recent EPS of $1.02 reflects profitable operations.
CDRE Revenue Growth, EPS Growth & YoY Performance
CDRE Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $130.1M | $2.0M | $0.05 |
| Q3 2025 | $109.4M | $3.7M | $0.09 |
| Q2 2025 | $144.3M | $6.9M | $0.30 |
| Q1 2025 | $130.1M | $6.9M | $0.18 |
| Q3 2024 | $109.4M | $3.7M | $0.09 |
| Q2 2024 | $121.1M | $6.9M | $0.29 |
| Q1 2024 | $111.7M | $6.9M | $0.18 |
| Q3 2023 | $111.6M | -$779.0K | $-0.02 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Cadre Holdings, Inc. Dividends, Buybacks & Capital Allocation
CDRE SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Cadre Holdings, Inc. (CIK: 0001860543)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CDRE
What is the AI rating for CDRE?
Cadre Holdings, Inc. (CDRE) has a Combined AI Grade of B from Claude (C) and ChatGPT (A) with 74% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are CDRE's key strengths?
Claude: Positive free cash flow generation of $19.8M with 12.8% FCF margin indicating cash generation capability. Adequate liquidity position with current ratio of 2.26x and quick ratio of 1.33x. ChatGPT: Strong liquidity profile with a 3.50x current ratio and 2.54x quick ratio. Healthy profitability, including 42.5% gross margin and double-digit operating margin.
What are the risks of investing in CDRE?
Claude: Critically low return on equity (0.6%) and return on assets (0.2%) indicate severe capital inefficiency. Net income flat year-over-year despite 7.5% revenue growth indicates margin deterioration and cost pressures offsetting top-line gains. ChatGPT: Net income was flat year over year despite 7.5% revenue growth, indicating limited operating leverage. Debt remains meaningful at 0.92x debt-to-equity with $290.99M in long-term debt.
What is CDRE's revenue and growth?
Cadre Holdings, Inc. reported revenue of $155.4M.
Does CDRE pay dividends?
Cadre Holdings, Inc. pays dividends, with $4.3M distributed to shareholders in the trailing twelve months.
Where can I find CDRE SEC filings?
Official SEC filings for Cadre Holdings, Inc. (CIK: 0001860543) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CDRE's EPS?
Cadre Holdings, Inc. has a diluted EPS of $0.05.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is CDRE's fundamental grade?
Based on our AI fundamental analysis in June 2026, Cadre Holdings, Inc. has a B grade with 74% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is CDRE stock overvalued or undervalued?
Valuation metrics for CDRE: ROE of 0.6% (sector avg: 15%), net margin of 1.3% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is CDRE's AI grade for 2026?
Our dual AI analysis gives Cadre Holdings, Inc. a combined B grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is CDRE's free cash flow?
Cadre Holdings, Inc.'s operating cash flow is $22.5M, with capital expenditures of $2.7M. FCF margin is 12.8%.
How does CDRE compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin 1.3% (avg: 12%), ROE 0.6% (avg: 15%), current ratio 2.26 (avg: 2).